A study funded by the National Institutes of Health has found that adults who were hospitalized for a severe infection, such ...
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle cell disease.
Low blood pressure, also known as hypotension, occurs when blood flows through your blood vessels at pressures that are lower than normal. Low blood pressure is primarily a concern if it produces ...
A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of Health (NIH) warning that the halt in the agency’s grant process could c ...
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to treat sickle cell disease (SCD). The trial aims to assess ...
The CDC, FDA, HHS and NIH have all been told to pause external communications, including publishing scientific reports, updating websites or issuing health advisories. The directive came without ...
The study is being sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institute of Health (NIH). Fostamatinib, marketed in the U.S. as TAVALISSE ...
The National Institutes of Health has awarded the Alliance for Advancing Biomedical Research a potential 25-year, $89 billion recompete contract to manage and operate a federally funded research ...
Although low blood pressure (otherwise known as hypotension) rarely requires treatment, it may need so if there are symptoms like severe dizziness or fainting. The treatment varies by the cause and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results